发展中国家造影剂所致急性肾损伤的长期随访研究

IF 2.5 Q2 PERIPHERAL VASCULAR DISEASE
International Journal of Vascular Medicine Pub Date : 2020-12-21 eCollection Date: 2020-01-01 DOI:10.1155/2020/8864056
Ashraf O Oweis, Sameeha A Alshelleh, Nesreen Saadeh, Mohamad I Jarrah, Rasheed Ibdah, Karem H Alzoubi
{"title":"发展中国家造影剂所致急性肾损伤的长期随访研究","authors":"Ashraf O Oweis,&nbsp;Sameeha A Alshelleh,&nbsp;Nesreen Saadeh,&nbsp;Mohamad I Jarrah,&nbsp;Rasheed Ibdah,&nbsp;Karem H Alzoubi","doi":"10.1155/2020/8864056","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Contrast-induced acute kidney injury (CI-AKI) is a worldwide known complication related to the use of contrast media with either imaging or angiography; it carries its own complications and effect on both morbidity and mortality; early identification of patients at risk and addressing modifiable risk factors may help reducing risk for this disease and its complications.</p><p><strong>Methods: </strong>This was a prospective observational study, where all patients admitted for cardiac catheterization between June 2015 and January 2016 were evaluated for CI-AKI. There were two study groups: contrast-induced acute kidney injury (CI-AKI) group, and noncontrast-induced acute kidney injury (non-CI-AKI) group.</p><p><strong>Results: </strong>Patients (<i>n</i> = 202) were included and followed up for 4 years. Death and development of chronic kidney disease (CKD) need for another revascularization were the end points. The incidence of CI-AKI was 14.8%.In univariate analysis, age (<i>P</i> = 0.016) and serum albumin at admission (<i>P</i> = 0.001) were statistically significant predictors of overall death. Age (<i>P</i> = 0.002), HTN (<i>P</i> = 0.002), DM (<i>P</i> = 0.02), and the use of diuretics (<i>P</i> = 0.001) had a statistically significant impact on eGFR. The rate of recatheterization was not statistically significant between the two groups (61 (35.5%) for the non-CI-AKI vs. 12 (40%) for the other group; <i>P</i> = 0.63). Some inflammatory markers (NGAL <i>P</i> = 0.06, IL-19 <i>P</i> = 0.08) and serum albumin at admission <i>P</i> = 0.07 had a trend toward a statistically significant impact on recatheterization. Death (<i>P</i> = 0.66) and need for recatheterization (<i>P</i> = 0.63) were not statistically different between the 2 groups, while the rate of eGFR decline in for the CI-AKI was significant (<i>P</i> = 0.004).</p><p><strong>Conclusion: </strong>CI-AKI is a common complication post percutaneous catheterization (PCI), which may increase the risk for CKD, but not death or the need for recatheterization. Preventive measures must be taken early to decrease the morbidity.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2020 ","pages":"8864056"},"PeriodicalIF":2.5000,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769673/pdf/","citationCount":"1","resultStr":"{\"title\":\"Long-Term Follow-Up of Contrast-Induced Acute Kidney Injury: A Study from a Developing Country.\",\"authors\":\"Ashraf O Oweis,&nbsp;Sameeha A Alshelleh,&nbsp;Nesreen Saadeh,&nbsp;Mohamad I Jarrah,&nbsp;Rasheed Ibdah,&nbsp;Karem H Alzoubi\",\"doi\":\"10.1155/2020/8864056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Contrast-induced acute kidney injury (CI-AKI) is a worldwide known complication related to the use of contrast media with either imaging or angiography; it carries its own complications and effect on both morbidity and mortality; early identification of patients at risk and addressing modifiable risk factors may help reducing risk for this disease and its complications.</p><p><strong>Methods: </strong>This was a prospective observational study, where all patients admitted for cardiac catheterization between June 2015 and January 2016 were evaluated for CI-AKI. There were two study groups: contrast-induced acute kidney injury (CI-AKI) group, and noncontrast-induced acute kidney injury (non-CI-AKI) group.</p><p><strong>Results: </strong>Patients (<i>n</i> = 202) were included and followed up for 4 years. Death and development of chronic kidney disease (CKD) need for another revascularization were the end points. The incidence of CI-AKI was 14.8%.In univariate analysis, age (<i>P</i> = 0.016) and serum albumin at admission (<i>P</i> = 0.001) were statistically significant predictors of overall death. Age (<i>P</i> = 0.002), HTN (<i>P</i> = 0.002), DM (<i>P</i> = 0.02), and the use of diuretics (<i>P</i> = 0.001) had a statistically significant impact on eGFR. The rate of recatheterization was not statistically significant between the two groups (61 (35.5%) for the non-CI-AKI vs. 12 (40%) for the other group; <i>P</i> = 0.63). Some inflammatory markers (NGAL <i>P</i> = 0.06, IL-19 <i>P</i> = 0.08) and serum albumin at admission <i>P</i> = 0.07 had a trend toward a statistically significant impact on recatheterization. Death (<i>P</i> = 0.66) and need for recatheterization (<i>P</i> = 0.63) were not statistically different between the 2 groups, while the rate of eGFR decline in for the CI-AKI was significant (<i>P</i> = 0.004).</p><p><strong>Conclusion: </strong>CI-AKI is a common complication post percutaneous catheterization (PCI), which may increase the risk for CKD, but not death or the need for recatheterization. Preventive measures must be taken early to decrease the morbidity.</p>\",\"PeriodicalId\":14448,\"journal\":{\"name\":\"International Journal of Vascular Medicine\",\"volume\":\"2020 \",\"pages\":\"8864056\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2020-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769673/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Vascular Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2020/8864056\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Vascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8864056","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 1

摘要

导语:造影剂引起的急性肾损伤(CI-AKI)是一种世界范围内已知的并发症,与造影剂与成像或血管造影的使用有关;它有自己的并发症,对发病率和死亡率都有影响;早期识别有风险的患者并处理可改变的风险因素可能有助于降低这种疾病及其并发症的风险。方法:这是一项前瞻性观察性研究,对2015年6月至2016年1月期间接受心导管插入术的所有患者进行CI-AKI评估。研究分为两组:对比剂诱导的急性肾损伤(CI-AKI)组和非对比剂诱导的急性肾损伤(non-CI-AKI)组。结果:纳入202例患者,随访4年。死亡和发展为慢性肾脏疾病(CKD)需要再次进行血运重建术是终点。CI-AKI发生率为14.8%。在单因素分析中,年龄(P = 0.016)和入院时血清白蛋白(P = 0.001)是总死亡的有统计学意义的预测因子。年龄(P = 0.002)、HTN (P = 0.002)、DM (P = 0.02)、利尿剂使用(P = 0.001)对eGFR有统计学意义。两组间再导管率无统计学意义(非ci - aki组61例(35.5%),另一组12例(40%);P = 0.63)。部分炎症指标(NGAL P = 0.06, IL-19 P = 0.08)和入院时血清白蛋白P = 0.07对再导管的影响有统计学意义。两组患者死亡(P = 0.66)和需要再导管(P = 0.63)无统计学差异,而CI-AKI患者eGFR下降率显著(P = 0.004)。结论:CI-AKI是PCI术后常见的并发症,可能增加CKD的风险,但不会增加死亡或再置管的必要性。必须及早采取预防措施,以降低发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Long-Term Follow-Up of Contrast-Induced Acute Kidney Injury: A Study from a Developing Country.

Long-Term Follow-Up of Contrast-Induced Acute Kidney Injury: A Study from a Developing Country.

Long-Term Follow-Up of Contrast-Induced Acute Kidney Injury: A Study from a Developing Country.

Introduction: Contrast-induced acute kidney injury (CI-AKI) is a worldwide known complication related to the use of contrast media with either imaging or angiography; it carries its own complications and effect on both morbidity and mortality; early identification of patients at risk and addressing modifiable risk factors may help reducing risk for this disease and its complications.

Methods: This was a prospective observational study, where all patients admitted for cardiac catheterization between June 2015 and January 2016 were evaluated for CI-AKI. There were two study groups: contrast-induced acute kidney injury (CI-AKI) group, and noncontrast-induced acute kidney injury (non-CI-AKI) group.

Results: Patients (n = 202) were included and followed up for 4 years. Death and development of chronic kidney disease (CKD) need for another revascularization were the end points. The incidence of CI-AKI was 14.8%.In univariate analysis, age (P = 0.016) and serum albumin at admission (P = 0.001) were statistically significant predictors of overall death. Age (P = 0.002), HTN (P = 0.002), DM (P = 0.02), and the use of diuretics (P = 0.001) had a statistically significant impact on eGFR. The rate of recatheterization was not statistically significant between the two groups (61 (35.5%) for the non-CI-AKI vs. 12 (40%) for the other group; P = 0.63). Some inflammatory markers (NGAL P = 0.06, IL-19 P = 0.08) and serum albumin at admission P = 0.07 had a trend toward a statistically significant impact on recatheterization. Death (P = 0.66) and need for recatheterization (P = 0.63) were not statistically different between the 2 groups, while the rate of eGFR decline in for the CI-AKI was significant (P = 0.004).

Conclusion: CI-AKI is a common complication post percutaneous catheterization (PCI), which may increase the risk for CKD, but not death or the need for recatheterization. Preventive measures must be taken early to decrease the morbidity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Vascular Medicine
International Journal of Vascular Medicine PERIPHERAL VASCULAR DISEASE-
CiteScore
3.50
自引率
0.00%
发文量
7
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信